I
Innate Pharma S.A. ADS
Biotechnology: Biological Products (No Diagnostic Substances) company
Key Metrics of Innate Pharma S.A. ADS
Revenue€70.5M▲ 0.0% YoYFY 2020
Operating income−€62.1M▲ 0.0% YoY
Net profit−€64.0M▲ 0.0% YoY
Shareholders' equity€156M
Market cap$168MIPHA · $1.50
Competitors10identified
About Innate Pharma S.A. ADS
Sectors
Company details
- Founded
- 2019
- Listed
- Nasdaq: IPHA (since 2019)
Operational Areas of Innate Pharma S.A. ADS
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameInnate Pharma S.A. ADS
TickerIPHA
ExchangeNasdaq
CountryFrance
SEC CIK0001598599
Listed since2019
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Website—
US market & SEC filings
IPHA · Nasdaq · SEC CIK 0001598599
Last price · 26 Oct 2026
$1.50
+0.00%
Market cap$168M
P/E—On FY 2020 diluted EPS
Volume11,924
SectorHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Country · IPOFranceListed 2019
IPHA share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Innate Pharma S.A. ADS
Competitors10identified
Countries2most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | gsk.com | 2022 | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
 Becton Dickinson |
Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | biomarin.com | 1999 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.